Palbociclib: Added Value of Long-term Efficacy, Safety and Real-world Data
Kyung-Hun Lee
(Seoul National Univ. Hospital, Korea)
09:30-10:15
Plenary Lecture 3
3
Venue: RM 1(Vista 1+2)
Moderators
Gyungyub Gong
(ASAN Medical Center, Korea)
Speakers
Genomic Biology of Triple Negative Breast Cancer
Edison Liu
(The Jackson Laboratory, U.S.A.)
10:30-11:45
Symposium 5:
Single Cell Proteogenomic and Translational Research in Breast Cancer10
Venue: RM 1(Vista 1+2)
Moderators
Andi K. Cani
(Univ. of Michigan, U.S.A.)
Eugene C. Yi
(Seoul National Univ.
, Korea)
Speakers
Single Cell Genomics in Breast Cancer
Amos Lee
(Seoul National Univ., Korea)
Single Cell Proteomic Technology and Future
Junho Park
(CHA Univ. College of Medicine, Korea)
Single Cell Genomics of Circulating Tumor Cells in Breast Cancer
Andi K. Cani
(Univ. of Michigan, U.S.A.)
Panel Discussion 4:
Treatment Dilemma in the Management of Breast Cancer18
Venue: RM 2(Vista 3)
Moderators
Byung Joo Chae
(Samsung Medical Center, Korea)
Mehra Golshan
(Yale School of Medicine, U.S.A.)
Speakers
Clinical Staging in Breast Cancer Patients Undergoing Neoadjuvant Treatment
Han-Byoel Lee
(Seoul National Univ. Hospital, Korea)
Can cT3/4 Breast Cancer be Safely Treated with Breast Conserving Surgery After Neoadjuvant Treatment?
Mehra Golshan
(Yale School of Medicine, U.S.A.)
Is Sentinel LN Biopsy Feasible in Clinical N2-3 Patients After Neoadjuvant Treatment?
Jean-Francois Boileau
(Jewish General Hospital, McGill Univ., U.S.A.)
Education Session 4:
Update of HER2+ Breast Cancer Treatment24
Venue: RM 3(Walker Hall 1)
Moderators
Kyung Hae Jung
(ASAN Medical Center, Korea)
Makiko Ono
(The Cancer Institute Hospital of JFCR, Japan)
Speakers
Systemic Treatment for HER2-positive Early Breast Cancer
Jee Hung Kim
(Yonsei Univ. College of Medicine, Korea)
Systemic Treatment for HER2-positive Metastatic Breast Cancer
Soo Chin Lee
(National Univ. Cancer Institute, Singapore)
Overview and Management of Adverse Events of Anti-HER2 ADCs
Makiko Ono
(The Cancer Institute Hospital of JFCR, Japan)
Oral Presentation 5
55
Venue: RM 4(Walker Hall 2)
Speakers
COMPARATIVE MICROBIOME ANALYSIS OF THE CONTRACTED BREAST CAPSULE USING NEXT GENERATION SEQUENCING
Tae Hyun Park
(Kyungpook National Univ. School of Medicine, Korea)
FACTORS RELATED TO PREGNANCY RATE AND TIMING AFTER BREAST CANCER TREATMENT IN YOUNG PATIENTS.
Young-Jin Lee
(ASAN Medical Center, Korea)
PRELIMINARY EFFICACY OF NEOADJUVANT NAB-PACLITAXEL AND PEMBROLIZUMAB-CONTAINING REGIMENS IN EARLY STAGED TRIPLE NEGATIVE BREAST CANCER (ETNBC) THERAPY
Sum Lung Jeffrey Wong
(Queen Mary Hospital, Hong Kong)
DP103-REGULATED P53-SUMO/ACETYLATION SWITCH DETERMINES RESPONSE TO DOCETAXEL IN ERΑ-POSITIVE BREAST CANCER
Alan Prem Kumar
(National Univ. of Singapore, Singapore)
KEY REGULATORS OF CHOLESTEROL AND LIPID METABOLISM AGGRAVATE BREAST CANCER
Sakshi Shukla
(All India Institute of Medical Sciences, New Delhi, India)
PATTERN AND COMPLICATION OF RECONSTRUCTED BREAST CANCER PATIENTS WHO RECEIVED POSTMASTECTOMY RADIOTHERAPY IN THE NATIONAL HEALTH INSURANCE SERVICE COHORT
Hyejo Ryu
(Seoul National Univ. College of Medicine, Korea)
MULTIDIMENSIONAL LONGITUDINAL ASSESSMENT OF TOXICITY AND COSMESIS AFTER HYPOFRACTIONATED WHOLE-BREAST RADIOTHERAPY FOR BREAST CANCER AMONG A PROSPECTIVE COHORT OF KOREAN WOMEN: A PRELIMINARY RESULT
Nalee Kim
(Samsung Medical Center, Korea)
IMPACT OF SURGICAL FACTORS ON AESTHETIC OUTCOME AFTER BREAST CONSERVATION THERAPY: A PROSPECTIVE COHORT STUDY
Shraddha Kenekar
(Tata Memorial Center, India)
BIODEGRADEBLE AND REDOX-RESPONSIVE NANOPARTICLE PLATFORM WITH TROP2 ANTIBODY LINKAGE FOR RNA INTERFERENCE TARGETING LNCRNA MNX1-AS1 TO REDUCE RADIO-RESISTANCE IN TRIPLE NEGATIVE BREAST CANCER
Qingjian Li
(Sun Yat-sen Memorial Hospital, China)
Nursing Session 1 (Kor.):
The Managements for Cognitive Impairment Related to Breast Cancer33
Venue: RM 5(Art Hall)
Moderators
Eun-Young Jun
(Daejeon Univ., Korea)
Nayeon Kim
(Samsung Medical Center, Korea)
Speakers
The Impact of Chemotherapy on Cognitive Impairments: Evidence and Implications
Hee-Ju Kim
(The Catholic Univ. of Korea, Korea)
The Cognitive Impairment in Breast Cancer Patients Undergoing Therapy
Hyejin Cho
(Ewha Womans Univ. Seoul Hospital, Korea)
Beneficial Effects of Exercise on Cancer-related Cognitive Impairment with Breast Cancer Patients
Seung-Soo Baek
(Sangmyung Univ., Korea)
12:00-12:45
Plenary Lecture 4
4
Venue: RM 1(Vista 1+2)
Moderators
In Ah Kim
(Seoul National Univ. Bundang Hospital, Korea)
Speakers
Breast-Cancer Related Lymphedema: Myths, Facts, Risk Factors and New Approach
Alphonse Taghian
(Massachusetts General Hospital, U.S.A.)
13:00-13:45
Satellite Symposium 3:
Lilly Korea47
Venue: RM 1(Vista 1+2)
Moderators
TBD
(, )
Speakers
Take Hope Further for HR+HER2-high-risk Early Breast Cancer Patients with Abemiciclib
Nadia Harbeck
(LMU Univ. Hospital, Germany)
14:00-14:45
Plenary Lecture 5
5
Venue: RM 1(Vista 1+2)
Moderators
Joon Jeong
(Gangnam Severance Hospital, Korea)
Speakers
Escalation and De-escalation of Breast Cancer Treatment
Michael Gnant
(Medical Univ. of Vienna, Austria)
15:00-16:15
Symposium 6:
The Role of Imaging in the Personalized Treatment11
Venue: RM 1(Vista 1+2)
Moderators
Woo Kyung Moon
(Seoul National Univ. Hospital, Korea)
Bo Kyoung Seo
(Korea Univ. Ansan Hospital, Korea)
Speakers
The Role of Imaging for the Management of DCIS
Mami Iima
(Kyoto Univ. Hospital, Japan)
The Role of DW-MRI in the Personalized Screening and Diagnosis
Savannah Partridge
(Univ. of Washington, U.S.A.)
Quantitative Imaging in Outcome Prediction of Breast Cancer
Vivian Youngjean Park
(Yonsei Univ. College of Medicine, Korea)
Panel Discussion 5:
Locoregional Treatment for Advanced/Recurrent Breast Cancer19
Venue: RM 2(Vista 3)
Moderators
Seung Ki Kim
(CHA Bundang Medical Center, Korea)
Andreas Karakatsanis
(Uppsala Univ. Hospital, Sweden)
Speakers
Surgical Extent After Neoadjuvant Chemotherapy
Geok Hoon Lim
(KK Women's and Children's Hospital, Singapore)
Role of Repeat Breast-conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence
Andreas Karakatsanis
(Uppsala Univ. Hospital, Sweden)
Radiation Therapy According to Residual Tumor Volume After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Sung-Ja Ahn
(Chonnam National Univ. Medical School, Korea)
Education Session 5:
Liquid Biopsy: New Era of Cancer Management25
Venue: RM 3(Walker Hall 1)
Moderators
Keun Seok Lee
(National Cancer Center, Korea)
Kan Yonemori
(National Cancer Center Hospital, Japan)
Speakers
Basic Technology of Liquid Biopsy
Eunhae Cho
(GC Genome, Korea)
Clinical Utility of Detection of Early Recurrence or Minimal Residual Disease Using Liquid Biopsy in Early Breast Cancer
Kan Yonemori
(National Cancer Center Hospital, Japan)
Current Advances of Liquid Biopsy in Tumor Burden Dynamics, Response Monitoring and Prognostic Marker in Metastatic Breast Cancer
Jisun Kim
(ASAN Medical Center, Korea)
Nursing Session 2 (Kor.):
Living and Care as Women with Hereditary Breast Cancer34
Venue: RM 5(Art Hall)
Moderators
Mi Young Kang
(Daerim St. Mary's Hospital, Korea)
Insook Lee
(Changwon National Univ., Korea)
Speakers
An Overview of Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome
Bom-Yi Lee
(Daerim St. Mary's Hospital, Korea)
Genetic Counseling for Hereditary Breast Cancer Patients
Ji Hye Yang
(ASAN Medical Center, Korea)
The Process of Choosing Cancer Risk-reducing Options in Women with Hereditary Breast Cancer: A Grounded Theory Study